20 participants
Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-19
- Start Date:
- 2022-11-30
- Completion:
- 2024-11-30
Conditions
- Pulmonary Fibrosis
- COVID-19 Respiratory Infection
Interventions
- DRUG
No Results Yet